{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:39:16Z","timestamp":1789630756641,"version":"build-2803163510"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is associated with disorders affecting the peripheral and the central nervous system. A high number of patients develop post-COVID-19 syndrome with the persistence of a large spectrum of symptoms, including neurological, beyond 4 weeks after infection. Several potential mechanisms in the acute phase have been hypothesized, including damage of the blood-brain-barrier (BBB). We tested weather markers of BBB damage in association with markers of brain injury and systemic inflammation may help in identifying a blood signature for disease severity and neurological complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood biomarkers of BBB disruption (MMP-9, GFAP), neuronal damage (NFL) and systemic inflammation (PPIA, IL-10, TNF\u03b1) were measured in two COVID-19 patient cohorts with high disease severity (ICUCovid; n=79) and with neurological complications (NeuroCovid; n=78), and in two control groups free from COVID-19 history, healthy subjects (n=20) and patients with amyotrophic lateral sclerosis (ALS; n=51). Samples from COVID-19 patients were collected during the first and the second wave of COVID-19 pandemic in Lombardy, Italy. Evaluations were done at acute and chronic phases of the COVID-19 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Blood biomarkers of BBB disruption and neuronal damage are high in COVID-19 patients with levels similar to or higher than ALS. NeuroCovid patients display lower levels of the cytokine storm inducer PPIA but higher levels of MMP-9 than ICUCovid patients. There was evidence of different temporal dynamics in ICUCovid compared to NeuroCovid patients with PPIA and IL-10 showing the highest levels in ICUCovid patients at acute phase. On the contrary, MMP-9 was higher at acute phase in NeuroCovid patients, with a severity dependency in the long-term. We also found a clear severity dependency of NFL and GFAP levels, with deceased patients showing the highest levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The overall picture points to an increased risk for neurological complications in association with high levels of biomarkers of BBB disruption. Our observations may provide hints for therapeutic approaches mitigating BBB disruption to reduce the neurological damage in the acute phase and potential dysfunction in the long-term.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2022.1070379","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:39:20Z","timestamp":1671097160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":81,"title":["Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations"],"prefix":"10.3389","volume":"13","author":[{"given":"Valentina","family":"Bonetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pasetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carbonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Zangari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Luotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bottino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Biagianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Moglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Canetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Montano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Camera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grimoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Rifino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Biroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Stocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa R.","family":"Zanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10581-y","article-title":"Neurological update: COVID-19","volume":"268","author":"Ren","year":"2021","journal-title":"J Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/s41467-022-29521-z","article-title":"Persistent COVID-19 symptoms in a community study of 606,434 people in England","volume":"13","author":"Whitaker","year":"2022","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13493","article-title":"Impact of the post-COVID-19 condition on health care after the first disease wave in Lombardy","volume":"292","author":"Mannucci","year":"2022","journal-title":"J Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ctn6020009","article-title":"Long COVID neuropsychological deficits after severe, moderate or mild infection","volume":"6","author":"Voruz","year":"2022","journal-title":"Clinical and Translational Neuroscience"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(22)00042-1","article-title":"Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study","volume":"7","author":"Magn\u00fasd\u00f3ttir","year":"2022","journal-title":"Lancet Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9081719","article-title":"Post-COVID-19 syndrome: Nine months after SARS-CoV-2 infection in a cohort of 354 patients: Data from the first wave of COVID-19 in nord franche-comt\u00e9 hospital, France","volume":"9","author":"Zayet","year":"2021","journal-title":"Microorganisms"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27309","article-title":"Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-a systematic review and meta-analysis","volume":"94","author":"Malik","year":"2022","journal-title":"J Med Virol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10517-6","article-title":"Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19","volume":"268","author":"Aamodt","year":"2021","journal-title":"J Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010111","article-title":"Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19","volume":"95","author":"Kanberg","year":"2020","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac321","article-title":"Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses","volume":"145","author":"Needham","year":"2022","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15293","article-title":"Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19","volume":"29","author":"Beghi","year":"2022","journal-title":"Eur J Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab302","article-title":"Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease","volume":"144","author":"Balcom","year":"2021","journal-title":"Brain"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052681","article-title":"Interactions of SARS-CoV-2 with the blood-brain barrier","volume":"22","author":"Erickson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001634","article-title":"The emerging role of perivascular cells (pericytes) in viral pathogenesis","volume":"102","author":"Butsabong","year":"2021","journal-title":"J Gen Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2891-16.2016","article-title":"Pericytes as inducers of rapid, matrix metalloproteinase-9-Dependent capillary damage during ischemia","volume":"37","author":"Underly","year":"2017","journal-title":"J Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-106","article-title":"Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-\u03b1, releasing matrix metalloproteinase-9 and migrating","volume":"8","author":"Takata","year":"2011","journal-title":"vitro. J Neuroinflamm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","article-title":"Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat","volume":"27","author":"Yang","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.570515","article-title":"Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9","volume":"41","author":"Barr","year":"2010","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3233\/JAD-150759","article-title":"Matrix metalloproteinase in blood-brain barrier breakdown in dementia","volume":"49","author":"Weekman","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein e controls cerebrovascular integrity via cyclophilin a","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2462-16.2016","article-title":"Targeting extracellular cyclophilin a reduces neuroinflammation and extends survival in a mouse model of amyotrophic lateral sclerosis","volume":"37","author":"Pasetto","year":"2017","journal-title":"J Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Trans Target Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41392-021-00760-8","article-title":"CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma","volume":"6","author":"Geng","year":"2021","journal-title":"Signal Trans Target Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10251-5","article-title":"Neurologic manifestations in 1760 COVID-19 patients admitted to papa Giovanni XXIII hospital, bergamo, Italy","volume":"268","author":"Rifino","year":"2021","journal-title":"J Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart Association\/American stroke association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"B28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 Syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12879-018-3570-2","article-title":"To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? results from a prospective observational study","volume":"19","author":"Quist-Paulsen","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1002331","DOI":"10.1371\/journal.ppat.1002331","article-title":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors","volume":"7","author":"Pfefferle","year":"2011","journal-title":"PloS Pathog"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200500177","article-title":"Redox regulation of cyclophilin a by glutathionylation","volume":"6","author":"Ghezzi","year":"2006","journal-title":"Proteomics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.052592699","article-title":"Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes","volume":"99","author":"Fratelli","year":"2002","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.8.3511","article-title":"Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages","volume":"89","author":"Sherry","year":"1992","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1958","article-title":"Cyclophilin a enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms","volume":"15","author":"Satoh","year":"2009","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2005.05.004","article-title":"Cyclophilin a may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages","volume":"116","author":"Kim","year":"2005","journal-title":"Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1038\/cddis.2013.410","article-title":"Cyclophilin a: a key player for human disease","volume":"4","author":"Nigro","year":"2013","journal-title":"Cell Death Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e041471","DOI":"10.1136\/bmjopen-2020-041471","article-title":"Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study","volume":"10","author":"Liu","year":"2020","journal-title":"BMJ Open"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00876-20","article-title":"Inhibition of SARS-CoV-2 infection by the cyclophilin inhibitor alisporivir (Debio 025)","volume":"64","author":"Softic","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2015.01.018","article-title":"EMMPRIN, an upstream regulator of MMPs, in CNS biology","author":"Kaushik","year":"2015","journal-title":"Matrix Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0168-0102(97)00119-3","article-title":"Expression of basigin, a member of the immunoglobulin superfamily, in the mouse central nervous system","volume":"30","author":"Fan","year":"1998","journal-title":"Neurosci Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","article-title":"SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Trans Target Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-7580.2002.00064.x","article-title":"Astrocyte-endothelial interactions and blood-brain barrier permeability","volume":"200","author":"Abbott","year":"2002","journal-title":"J Anat"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.835597","article-title":"GFAP and S100B: What you always wanted to know and never dared to ask","volume":"13","author":"Janigro","year":"2022","journal-title":"Front Neurol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1126\/scitranslmed.abg9922","article-title":"Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury","author":"Graham","year":"2021","journal-title":"Sci Transl Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2033369","article-title":"Microvascular injury in the brains of patients with covid-19","volume":"384","author":"Lee","year":"2021","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302312","article-title":"Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies","volume":"84","author":"Kanda","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12987-022-00365-5","article-title":"Microglia-derived CCL2 has a prime role in neocortex neuroinflammation","volume":"19","author":"Errede","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"B49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15321","article-title":"Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis","volume":"29","author":"Falzone","year":"2022","journal-title":"Eur J Neurol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study","volume":"3","author":"Gissl\u00e9n","year":"2016","journal-title":"EBioMedicine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e116081","DOI":"10.1371\/journal.pone.0116081","article-title":"Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection","volume":"9","author":"Peterson","year":"2014","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2017.1341313","article-title":"Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls","volume":"17","author":"Yilmaz","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112260","article-title":"Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview","volume":"194","author":"Mondal","year":"2020","journal-title":"Eur J Med Chem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-021-00603-6","article-title":"Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial","volume":"6","author":"Bian","year":"2021","journal-title":"Signal Trans Target Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16141","article-title":"Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2","volume":"20","author":"Rodriguez-Cubillo","year":"2020","journal-title":"Am J Transplant"},{"key":"B59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12987-016-0043-0","article-title":"The restorative role of annexin A1 at the blood\u2013brain barrier","volume":"13","author":"McArthur","year":"2016","journal-title":"Fluids Barriers CNS"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101297R","article-title":"Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood-brain barrier: Therapeutic avenues","volume":"36","author":"Sheikh","year":"2022","journal-title":"FASEB J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jama.2022.11691","article-title":"Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers","volume":"328","author":"Azzolini","year":"2022","journal-title":"JAMA"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101624","article-title":"Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review","volume":"53","author":"Notarte","year":"2022","journal-title":"eClinicalMedicine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1070379\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:39:23Z","timestamp":1671097163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1070379\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2022.1070379"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1070379","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.09.26.22280358","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"1070379"}}